CNS Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q3 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q1 2024.
  • CNS Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $6.63K, a 21.9% increase year-over-year.
  • CNS Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $15K, a 51.5% increase year-over-year.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2023 was $13.8K, a 96.5% increase from 2022.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2022 was $7.03K, a 24.3% decline from 2021.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2021 was $9.29K, a 184% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15K $6.63K +$1.19K +21.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $13.8K $2.88K +$569 +24.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $13.2K $1.84K +$1.3K +242% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $11.9K $3.65K +$2.04K +127% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $9.9K $5.44K +$2.87K +112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $7.03K $2.31K +$74.00 +3.31% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $6.95K $538 -$409 -43.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.36K $1.61K -$742 -31.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $8.1K $2.57K -$1.18K -31.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $9.29K $2.24K -$1.03K -31.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $10.3K $947 +$947 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $9.36K $2.35K +$2.35K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $7.01K $3.75K +$3.75K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $3.26K $3.26K -$353 -9.76% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $3.62K $0 -$7.56K -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $11.2K $0 -$7.48K -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $18.7K $0 -$7.49K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $26.2K $3.62K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-12
Q3 2019 $7.56K -$3.07K -28.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $7.48K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $7.49K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $10.6K Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.